Positive Outlooks

Stories to make you feel better.

☰
  • Home
    • About Us
  • Stories
    • Health | Wellness
    • Quotes
  • Reflections
  • Submissions
  • Contact Us
  • Home
  • Johnson & Johnson

Nasal spray could help those who have no success with available depression treatments

Recently, the U.S. FDA approved esketamine, a fast-acting drug derived from the anesthetic, ketamine, that is intended to aid the treatment-resistant population of people with depression. There are about 16.2 million Americans who suffer from major depression, and as many as a quarter of them reported achieving little to no results from available treatments, including FDA

Read more →

Tagged with 
depression esketamine health Janssen Pharmaceuticals Johnson & Johnson ketamine medical treatment medicines pharmaceutical innovation science Spravato
 
Follow us on Pinterest!
Categories
Archives
Follow Us
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
Our TOP Stories
‘I am going to find you the perfect woman and she is going to love my daughters.'
Police officer adopts little girl he rescued from abuse and comforted her while on duty
Woman's off-grid tiny house truck is every solo female traveler's dream, take a look inside
Shelter puppy smiles at everyone who walks by in adorable attempt to get adopted

Privacy Policy of Positive Outlooks
×Close